Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Payments for finance leases

Payments for finance leases at other companies

Rogers Corporation logo
Rogers CorporationROG
$300K-25.0%
LQD
Liquidia CorporationLQDA
$0-100%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$7K0.0%
Incyte logo
IncyteINCY
$1.18M+8.6%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's payments for finance leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's payments for finance leases?
Aurinia Pharmaceuticals (AUPH) reported payments for finance leases of $3.65M in Q1 2026.
How has Aurinia Pharmaceuticals's payments for finance leases changed year-over-year?
Aurinia Pharmaceuticals's payments for finance leases increased by 31.8% year-over-year, from $2.77M to $3.65M.
What does payments for finance leases mean?
Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.